These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24429106)

  • 1. Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS.
    Simithy J; Reeve N; Hobrath JV; Reynolds RC; Calderón AI
    Tuberculosis (Edinb); 2014 Mar; 94(2):152-8. PubMed ID: 24429106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an ESI-LC-MS-based assay for kinetic evaluation of Mycobacterium tuberculosis shikimate kinase activity and inhibition.
    Simithy J; Gill G; Wang Y; Goodwin DC; Calderón AI
    Anal Chem; 2015 Feb; 87(4):2129-36. PubMed ID: 25629762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an ultrafiltration-liquid chromatography/mass spectrometry (UF-LC/MS) based ligand-binding assay and an LC/MS based functional assay for Mycobacterium tuberculosis shikimate kinase.
    Mulabagal V; Calderón AI
    Anal Chem; 2010 May; 82(9):3616-21. PubMed ID: 20394394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
    Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
    Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
    Segura-Cabrera A; Rodríguez-Pérez MA
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3152-7. PubMed ID: 18486472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid.
    Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; Santos DS; de Azevedo WF
    Acta Crystallogr D Biol Crystallogr; 2004 Dec; 60(Pt 12 Pt 2):2310-9. PubMed ID: 15583379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multifaceted approach to identify non-specific enzyme inhibition: Application to Mycobacterium tuberculosis shikimate kinase.
    Alturki MS; Fuanta NR; Jarrard MA; Hobrath JV; Goodwin DC; Rants'o TA; Calderón AI
    Bioorg Med Chem Lett; 2018 Feb; 28(4):802-808. PubMed ID: 29366649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of irreversible inhibition of Mycobacterium tuberculosis shikimate kinase by ilimaquinone.
    Simithy J; Fuanta NR; Hobrath JV; Kochanowska-Karamyan A; Hamann MT; Goodwin DC; Calderón AI
    Biochim Biophys Acta Proteins Proteom; 2018; 1866(5-6):731-739. PubMed ID: 29654976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis.
    Kumar M; Verma S; Sharma S; Srinivasan A; Singh TP; Kaur P
    Chem Biol Drug Des; 2010 Sep; 76(3):277-84. PubMed ID: 20626408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.
    Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A
    J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shikimate kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: kinetics and structural dynamics of a potential molecular target for drug development.
    Saidemberg DM; Passarelli AW; Rodrigues AV; Basso LA; Santos DS; Palma MS
    Curr Med Chem; 2011; 18(9):1299-310. PubMed ID: 21366533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of Mycobacterium tuberculosis shikimate kinase in complex with shikimic acid and an ATP analogue.
    Gan J; Gu Y; Li Y; Yan H; Ji X
    Biochemistry; 2006 Jul; 45(28):8539-45. PubMed ID: 16834327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shikimate Kinase Inhibitors: An Update on Promising Strategy against
    Rajput VS; Runthala A; Khan IA
    Curr Drug Targets; 2023; 24(5):388-405. PubMed ID: 36752299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Schaeffer's acid analogues as lead structures of mycobacterium tuberculosis type II dehydroquinase using a rational drug design approach.
    Schmidt MF; Korb O; Howard NI; Dias MV; Blundell TL; Abell C
    ChemMedChem; 2013 Jan; 8(1):54-8. PubMed ID: 23169689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of shikimic acid with shikimate kinase.
    Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; de Azevedo WF; Santos DS
    Biochem Biophys Res Commun; 2004 Dec; 325(1):10-7. PubMed ID: 15522194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, molecular docking, and biological evaluation of novel 1,2,4-triazole-isatin derivatives as potential Mycobacterium tuberculosis shikimate kinase inhibitors.
    Dadlani VG; Chhabhaiya H; Somani RR; Tripathi PK
    Chem Biol Drug Des; 2022 Aug; 100(2):230-244. PubMed ID: 35434882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based Discovery of Narirutin as a Shikimate kinase Inhibitor with Anti-tubercular Potency.
    Sahu PK; Mohapatra PK; Rajani DP; Raval MK
    Curr Comput Aided Drug Des; 2020; 16(5):523-529. PubMed ID: 31654517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of mechanism and chemical inhibitors of shikimate kinase.
    Chagaleti BK; Reddy MBR; Saravanan V; B S; D P; Senthil Kumar P; Kathiravan MK
    J Biomol Struct Dyn; 2023; 41(23):14582-14598. PubMed ID: 36974959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium tuberculosis shikimate kinase inhibitors: design and simulation studies of the catalytic turnover.
    Blanco B; Prado V; Lence E; Otero JM; Garcia-Doval C; van Raaij MJ; Llamas-Saiz AL; Lamb H; Hawkins AR; González-Bello C
    J Am Chem Soc; 2013 Aug; 135(33):12366-76. PubMed ID: 23889343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments.
    Freitas de Freitas T; Roth CD; Abbadi BL; Hopf FSM; Perelló MA; de Matos Czeczot A; de Souza EV; Borsoi AF; Machado P; Bizarro CV; Basso LA; Timmers LFSM
    J Comput Aided Mol Des; 2023 Mar; 37(3):117-128. PubMed ID: 36547753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.